This role will partner cross-functionally to assess the commercial potential of internal and external opportunities for Vertex's Sandbox. This will include the commercial assessment of new disease areas to be added to the Sandbox as well as the assessment of all potential external assets and new technologies to support existing or emerging Sandbox diseases.
This dynamic and high-profile role will play an important part in setting the strategic direction of Vertex's disease areas of interest and the assets and technologies available to deliver commercial success. This position will report to the Director, Commercial Assessments, within Global Marketing.
- Lead the commercial assessments of new disease areas, targets, and platforms, working closely with Research, Development, Real World Evidence, Business Development, Finance and Pricing & Reimbursement
- Assess internal and external disease programs, targets, or technology to determine if they fit the Vertex Commercial Model
- Identify new disease areas for Vertex Sandbox consideration and determine if they merit detailed evaluation
- Lead competitive intelligence efforts for new opportunities
- Contribute to the commercial section of BD assessments and represent commercial during due diligence
- Represent and report on commercial assessments to the Science and Sandbox Extension Committee for review and approval by Executive Committee
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston's Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 2,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development.
Vertex is consistently recognized as one of the industry's top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards. For additional information and the latest updates from the Company, please visit www.vrtx.com.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law. Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at ApplicationAssistance@vrtx.com.